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Accuracy of hydrocortisone dose administration via nasogastric 
tube




















Objectiver	Hydrocortisone	 via	 nasogastric	 ｪNGｫ	 tube	 is	 used	 in	 sick	 chi旭dren	with	





















K E Y W O R D S
bioavai旭abi旭ityp	cortiso旭p	hydrocortisonep	nasogastric	tubesp	paediatric
ゲ科 |科INTRODUC TION
Long､term	 treatment	 with	 hydrocortisone	 is	 required	 in	 chi旭､




a	nasogastric	 ｪNGｫ	 tube	during	 inter､current	 i旭旭nessp	and	 treatment	
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with	hydrocortisone	to	reduce	bronchopu旭monary	dysp旭asia	in	pre､
mature	 infants	 is	 becoming	more	 popu旭arジq	 howeverp	 there	 are	 no	
旭icensed	formu旭ations	for	administration	via	NG	tubes





potentia旭旭y	 poor	 旭ong､term	 hea旭th	 outcomess葦､芦	 For	 hydrocortisone	















The	experimenta旭	 protoco旭	was	deve旭oped	 fo旭旭owing	 consu旭tation	
with	adu旭t	and	paediatric	endocrine	specia旭ist	nursesp	senior	neo､










age	groups	The	protoco旭	was	 tested	on	 the	bench	mu旭tip旭e	 timesp	
timed	 and	 supervised	 by	 a	 paediatric	 endocrine	 nurse	 to	 ensure	
comp旭iance	with	c旭inica旭	practices	Two	researchers	performed	the	
experiments	and	a旭旭	stages	were	timed	for	standardizations
ゴsゴ科|科Protoco旭 for preparation of hydrocortisone 
formulations for administration
ｨ	 Liquid	 hydrocortisone	 suspensionr	 the	 bott旭e	 ｪゲググ	mL	 bott旭e	









ゴsザ科|科Hydrocortisone recovery at the nasa旭 
end of the NG tube



















ends	The	administration	of	 a旭旭	 three	preparations	was	 tested	using	
transparent	葦p	芦p	ゲグ	and	ゲゴFr	NG	tubes	to	cover	the	size	range	used	













ゴsズ科|科A旭ternative method for preparation of 
hydrocortisone granules for administration
A	second	method	of	samp旭e	preparation	for	hydrocortisone	gran､
u旭es	 was	 deve旭oped	 to	 test	 the	 feasibi旭ity	 of	 neonata旭	 size	 ｪ葦Frｫ	
NG	administration	and	assess	the	recovery	of	hydrocortisones	 In	
a	 bijou	 tubep	 ゴ	mg	 of	 hydrocortisone	 granu旭es	 were	 suspended	
in	 ゴ	mL	 steri旭e	 waterp	 the	 suspension	 was	 shaken	 vigorous旭y	
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for	 ザグ	seconds	 and	 a旭旭owed	 to	 rest	 on	 the	 bench	 for	 グp	 ゲズp	 ザグp	
ジズ	 or	 葦グ	minutesp	 then	 shaken	 vigorous旭y	 again	 for	 ザグ	secondss	
Immediate旭y	 afterwardsp	 ゲ	mL	 of	 suspension	 ｪtarget	 dose	 ゲ	mgｫ	
was	aspirated	into	a	ゴsズ	mL	steri旭e	syringe	through	a	meta旭旭ic	sam､
p旭ing	need旭e	used	for	aspirating	drugs	for	ora旭	administration	that	




bijou	 tube	 ｪcontro旭	 samp旭eｫs	With	 the	 same	 syringep	 ゴ	mL	 steri旭e	
water	was	aspirated	and	then	f旭ushed	into	the	NG	tube	ｪNG	pas､
sage	samp旭eｫ	or	expe旭旭ed	into	the	contro旭	samp旭ess	The	NG	tubes	
were	 旭eft	 to	drain	 into	 the	bijou	 tubes	 for	ザ	minutes	and	 the	ex､
periment	was	repeated	five	timess
ゴs葦科|科Quantification of hydrocortisone by 旭iquid 
chromatography tandem mass spectrometry
A旭旭	 samp旭es	 were	 旭abe旭旭ed	 with	 a	 numerica旭	 codep	 stored	 at	
ジﾀC	 and	 transferred	 on	 ice	 for	 旭iquid	 chromatography､tandem	
mass	 spectrometry	 ｪLC､MS｠MSｫ	 ana旭ysis	 of	 hydrocortisone	 at	
the	 Biochemistry	 Departmentp	 Manchester	 University	 NHSA	
Foundation	 Trusts	 Prior	 to	 ana旭ysis	 the	 samp旭es	 were	 warmed	
in	 a	hot	bath	 for	ズ	minutesp	 shaken	and	a	ゲrゲグ	グググ	di旭ution	with	
water	 was	 mades	 The	 LC､MS｠MS	 method	 has	 been	 described	
e旭sewhere20	 but	 brief旭yp	 standardp	 qua旭ity	 contro旭	 or	 hydrocorti､





then	 centrifuged	 at	 芦グググ	g	 for	 ズ	minutess	 Fo旭旭owing	 centrifuga､
tionp	 the	 p旭ate	 was	 transferred	 direct旭y	 to	 the	 autosamp旭er	 for	
ana旭ysisq	ゲグ	μL	of	samp旭e	was	 injected	 into	the	 旭iquid	chromatog､
raphy	 ｪLCｫ	 system	 using	 partia旭	 旭oop	modes	 LC､MS｠MS	was	 per､
formed	using	an	Acquity	I	C旭ass	coup旭ed	to	a	XEVO	TQ､D	detector	
ｪWatersp	Wi旭ms旭owp	UKｫs	The	quantity	of	hydrocortisone	in	mg	in	
each	 samp旭e	was	 ca旭cu旭ated	 from	 the	 hydrocortisone	 concentra､
tions	 The	 inter､assay	 imprecision	 ｪ鯵CVｫ	was	 ゲザ鯵p	 ゾ鯵	 and	 ズ鯵	 at	
concentrations	 of	 ゲググp	 ジググ	 and	 芦ググ	nmo旭｠Lp	 respective旭ys	 The	
intra､assay	imprecision	was	ゲゴ鯵p	ゼ鯵	and	ゾ鯵s
ゴsゼ科|科Data presentation and statistica旭 ana旭ysis
Resu旭ts	are	shown	as	mean	┓	SD	of	the	repeatss	The	data	are	ex､
pressed	 either	 as	mean	 hydrocortisone	 content	 in	mg	 or	鯵	 hy､
drocortisone	recoveryp	that	isp	the	mean	hydrocortisone	content	
in	each	set	expressed	as	a	percentage	of	 the	dose	administered	
ｪtarget	 doseｫs	 ANOVA	 with	 mu旭tip旭e	 comparisons	 was	 used	 for	
the	 ana旭ysis	 of	 differences	 between	 the	 three	 hydrocortisone	
formu旭ations	 and	 between	 the	 bench	 time	 rest	 periods	 a旭旭owed	
for	the	a旭ternative	preparation	method	for	hydrocortisone	gran､
u旭es	 suspension	 ｪGraphPad	ゼp	GraphPad	Softwarep	 La	 Jo旭旭a	CAｫs	
Unpaired	 two､tai旭ed	 t	 tests	 were	 performed	 for	 comparison	 of	
pre､	and	post､NG	administration	recovery	for	each	time	point	in	
the	 a旭ternative	method	 of	 preparations	 A	P	 va旭ue	 of	 ┑グsグズ	was	
considered	significants
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ザ科 |科RESULTS
ザsゲ科|科Recovery of hydrocortisone prior to NG 
administration
The	 recovery	 of	 hydrocortisone	 from	 a旭旭	 three	 preparations	 at	
the	nasa旭	end	of	the	NG	tube	prior	to	NG	administration	was	旭owr	




cortisone	 with	 hydrocortisone	 granu旭es	 was	 significant旭y	 better	





the	 administrating	 syringeq	 mean	┓	SD	鯵	 recovery	 of	 target	 doseq	
グsズ	mg	dose	without	f旭ushing	ズゼ鯵	┓	ゼ鯵	vs	with	f旭ushing	ゲジゼ鯵	┓	ザゲ鯵	
ｪP	┑	グsグゲｫq	 ゴ	mg	dose	without	 f旭ushing	ズ芦鯵	┓	ゲ芦鯵	vs	with	 f旭ushing	
ゲグズ鯵	┓	芦鯵	ｪP	┑	グsグゲp	Figure	ゴｫs	Based	on	these	resu旭ts	syringes	for	a旭旭	
formu旭ations	were	f旭ushed	for	the	experiments	using	the	NG	tubess
ザsゴ科|科Hydrocortisone recovery after passage 
through NG tubes
In	this	in	vitro	settingp	it	was	possib旭e	to	administer	hydrocortisone	
through	 neonata旭p	 paediatric	 and	 ado旭escent	 size	NG	 tubes	 using	
a旭旭	three	preparationsp	a旭though	the	de旭ivery	was	variab旭es	The	hy､
drocortisone	 granu旭es	 and	 the	 旭iquid	 suspension	 showed	 simi旭ar	
resu旭ts	throughout	the	range	of	NG	tube	sizes	whereas	the	crushed	





















ザsザ科|科Recovery of hydrocortisone from 




TA B L E  ゲ 科The	recovery	of	hydrocortisone	from	three	different	hydrocortisone	formu旭ations	administered	through	NG	tubesp	co旭旭ected	
with	water	f旭ush	and	quantified	by	LC､MS
グsズ mg dose 2 mg dose
Mean in mg Standard deviation
% delivery of 
target dose Mean in mg Standard deviation
% delivery of 
target dose
Liquid	suspension
葦Fr グsジ葦 グsゲゼ ゾゴ鯵 ゲsゴ葦 0.31 葦ザ鯵
芦Fr グsジ葦 グsグ葦 ゾゲ鯵 ゲsゴゾ グsゲ葦 葦ジ鯵
ゲグFr 0.32 グsゲ葦 葦ズ鯵 1.22 グsゴゼ 葦ゲ鯵
ゲゴFr グsザゾ 0.10 ゼ芦鯵 ゲsゴゾ 0.12 葦ズ鯵
Crushed	tab旭ets
葦Fr グsゴゾ 0.11 ズゾ鯵 0.81 グsグゾ ジグ鯵
芦Fr 0.38 グsゲ葦 ゼゼ鯵 0.83 0.18 ジゴ鯵
ゲグFr グsザズ グsグズ ゼグ鯵 0.83 グsゲジ ジゴ鯵
ゲゴFr グs芦ゼ グsズゾ ゲゼジ鯵 ゲsゾゲ グs葦芦 ゾ葦鯵
Hydrocortisone	granu旭es
葦Fr 0.33 グsグゼ 葦葦鯵 1.23 グsゲジ 葦ゲ鯵
芦Fr 0.33 0.02 葦葦鯵 ゲsザズ グsゴジ 葦ゼ鯵
ゲグFr グsザ葦 グsグズ ゼゴ鯵 1.38 グsグ葦 葦ゾ鯵
ゲゴFr グsジゴ グsグゾ 芦ザ鯵 ゲs芦ジ グsゴゼ ゾゴ鯵









post､NG	 passage	 samp旭es	 ｪP	┑	グsグゲp	 Figure	 ズｫs	 For	 post､NG	 tube	
passage	the	recovery	was	as	fo旭旭owsr	グ	minutes	ゲジ鯵	┓	ジ鯵p	ゲズ	min､















F I G U R E  ザ 科Mean	hydrocortisone	content	after	preparation	in	a	syringep	administration	through	NG	tubes	gauge	葦､ゲゴFr	fo旭旭owed	by	
f旭ushing	ｪAｫ	Hydrocortisone	dose	グsズ	mg	and	ｪBｫ	Hydrocortisone	dose	ゴsグ	mg
葦科 |科 科架 DANIEL ET AL.
crushed	tab旭ets	where	in	some	cases	recovery	was	┑ズグ鯵	of	the	dose	
















hydrocortisone	 tab旭ets	 have	 been	 found	 to	 have	 unacceptab旭y	
variab旭e	 drug	 content	 in	 over	 ゴグ鯵	 of	 batches	 and	 have	 旭ed	 to	
c旭inica旭旭y	 and	 biochemica旭旭y	 evident	 g旭ucocorticoid	 overtreat､





the	 target	dose	 ｪグsズ	mg	or	ゴ	mgｫ	was	 recovered	 in	 the	 samp旭es	
This	旭ike旭y	ref旭ects	prob旭ems	with	the	current	practice	of	prepar､
ing	 sma旭旭	 doses	 from	ゲグ	mg	 adu旭t	 dose	 tab旭etss	Another	 factor	
cou旭d	be	the	旭oss	of	active	pharmaceutica旭	ingredient	that	cou旭d	
be	up	 to	ゲグ鯵	of	 the	mass	during	hydrocortisone	compounding	




Few	 studies	 have	 reported	 the	 administration	 of	 medications	
through	NG	tubes	and	none	have	reported	on	hydrocortisonesゴ葦､ゴゾ 
Our	resu旭ts	show	suboptima旭	recovery	of	hydrocortisone	at	the	gas､
tric	 ends	High	variabi旭ity	 and	 旭ow	 recovery	of	medications	 such	as	
proton､pump	inhibitors	administered	through	NG	tubes	were	com､
mon旭y	 observed	 in	 in	 vitro	 studies	 and	 recovery	 increased	 when	
higher	vo旭umes	of	so旭vent	were	used	for	drug	disso旭ution	prior	to	NG	
administration	and	f旭ushing	of	 the	equipmentsゲゼpゴ葦､ゴ芦	Simi旭ar	 to	our	
observationp	 formu旭ations	 consisting	 of	 granu旭es	 frequent旭y	 cause	
NG	tube	obstructionssザグpザゲ
F I G U R E  ジ 科Hydrocortisone	granu旭es	occ旭uding	葦Fr	NG	tube
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It	 is	 important	to	fo旭旭ow	appropriate	techniques	when	admin､
istering	medications	down	NG	 tubes	and	 this	 app旭ies	 to	patients	





This	 has	 imp旭ications	 in	 chi旭dren	 treated	with	 hydrocortisone	 via	
the	 ora旭	 route	when	 intervening	 equipment	 such	 as	 syringes	 are	
usedq	f旭ushing	of	devices	is	important	to	maximize	recovery	for	hy､
drocortisonep	which	 is	poor旭y	so旭ub旭e	 in	water	and	sticks	 to	p旭as､





for	 rep旭acement	 therapy	 of	 paediatric	 adrena旭	 insufficiency	 and	
according	to	the	summary	of	product	characteristics	they	are	not	
suitab旭e	for	administration	through	nasogastric	tubess13	Consistent	
with	 thisp	we	 found	 that	hydrocortisone	granu旭es	b旭ocked	 sma旭旭er	
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